Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes
Journal of Proteome Research · 02.02.2024 · 23 (2) · 797-808
DOI: 10.1021/acs.jproteome.3c00700 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, online erschienen am 11.01.2024. Verfasst von Dongdong Qi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University-Town Hospital of Chongqing Medical University, Chongqing 401331, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
The objective of this study was to construct a prognostic model by utilizing serine/glycine metabolism-related genes (SGMGs), thus establishing a risk score for lung adenocarcinoma (LUAD). Based on the TCGA-LUAD and SGMG data set, two subtypes with different SGMG expression levels were identified by clustering analysis. Thirteen differential expression genes were used to construct RiskScore by Cox regression. GSE72094 data set was used for validation. The survival characteristics, immune features, and potential benefits of chemotherapy drugs were analyzed for two risk groups. RiskScore was constructed based on the genes ABCC12, RIC3, CYP4B1, SFTPB, CACNA2D2, IGF2BP1, NTSR1, DKK1, CREG2, PITX3, RGS20, FETUB, and IGFBP1. Patients in the low-risk (LR) group exhibited a superior overall survival. In addition, aDCs, iDSs, mast cells, neutrophils, HLA, and type II IFN were more abundant in the LR group with higher IPS scores and lower TIDE scores. In contrast, NK cells, APC coinhibition, and MHC-I were more common in the high-risk (HR) group, which may be more sensitive to chemotherapy drugs such as cisplatin, oxaliplatin, and nilotinib. RiskScore was a promising biomarker that can be used to distinguish LUAD prognosis, immune features, and sensitivity to chemotherapy drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, University-Town Hospital of Chongqing Medical University, Chongqing 401331, China.
ORCID-Profile: Poming Kang
Zitieren
APA
Qi, D., Liu, C., Zhang, Z., Liu, X., & Kang, P. (2024). Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes. Journal of Proteome Research, 23(2), 797-808. https://doi.org/10.1021/acs.jproteome.3c00700
Vancouver
Qi D, Liu C, Zhang Z, Liu X, Kang P. Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes. Journal of Proteome Research. 2024;23(2):797-808. doi:10.1021/acs.jproteome.3c00700
BibTeX
@article{Qi2024,
author = {Qi, Dongdong and Liu, Chengjun and Zhang, Zuwang and Liu, Xun and Kang, Poming},
title = {Construction of a Lung Adenocarcinoma Prognostic Model Utilizing Serine and Glycine Metabolism-Related Genes},
journal = {Journal of Proteome Research},
year = {2024},
volume = {23},
number = {2},
pages = {797--808},
doi = {10.1021/acs.jproteome.3c00700}
}
EUVIMED